| Indicators | Browse All

Whitehawk Therapeutics, Inc. (WHWK)

Healthcare | Biotechnology | Morristown, United States | NasdaqCM
3.84 USD -0.13 (-3.275%) ⇩ (July 13, 2026, 4 p.m. EDT)

Short-term:★⯪☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 5:33 a.m. EDT

Whitehawk Therapeutics presents a classic biotech value trap where a recovering stock price masks deteriorating fundamentals. While the company recently secured $87.5 million in financing and was added to major indices, the underlying business is bleeding cash aggressively, with operating and free cash flows both deeply negative. The balance sheet is fragile, holding only $123 million in cash against substantial burn rates, and the stock trades at a negative forward P/E, confirming that analysts see no path to profitability soon. The price action shows a recent bounce, moving from lows near $1.50 to nearly $4.50, but this rally lacks the volume and breadth to suggest a sustainable trend reversal. More concerning is the options flow: traders are buying protection at lower strikes rather than betting on a breakout, signaling skepticism about the upside. Although the statistical forecast model hints at a slight upward lean, its low reliability score suggests this is likely just noise. Until the company demonstrates a clear path to reducing its cash burn or generating positive operating cash flow, the risk of capital destruction remains high.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL_70 ✓0.045336
MSTL_70_1050.066291
MSTL0.074259
AutoARIMA0.074485
AutoETS0.074514
MSTL_1050.095287
AutoTheta0.113263

Forecast horizon: 60 days | Selected: MSTL_70

Forecast Reliability
Score 32%
H-stat 0.62
Ljung-Box p 0.000
Jarque-Bera p 0.008
Excess Kurtosis 0.79
Attribute Value
Sector Healthcare
Market Cap 189,897,456
Forward P/E -3.45
Beta 0.77
Previous Name Aadi Bioscience, Inc.
Website https://ir.whitehawktx.com

As of July 11, 2026, 5:33 a.m. EDT: Speculators are positioning defensively with heavy open interest in out-of-the-money puts at the $2.50 strike, suggesting a fear of further downside or a floor test. Conversely, call activity is sparse and concentrated at the $5.00 strike, indicating limited bullish conviction despite the recent price recovery. Implied volatility is elevated on near-term puts relative to calls, reflecting asymmetric risk pricing.


Info Dump

Attribute Value
52 Week Change 0.97938144
Address1 2 Headquarters Plaza
Address2 East Building 11th Floor
All Time High 78.0
All Time Low 1.21
Ask 4.87
Ask Size 2
Audit Risk 7
Average Analyst Rating 1.9 - Buy
Average Daily Volume10 Day 595,200
Average Daily Volume3 Month 467,724
Average Volume 467,724
Average Volume10Days 595,200
Beta 0.769
Bid 2.92
Bid Size 2
Board Risk 6
Book Value 2.462
City Morristown
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 9
Country United States
Crypto Tradeable 0
Currency USD
Current Price 3.84
Current Ratio 11.356
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 4.06
Day Low 3.81
Display Name Whitehawk Therapeutics
Earnings Call Timestamp End 1,742,387,400
Earnings Call Timestamp Start 1,742,387,400
Earnings Timestamp 1,778,157,000
Earnings Timestamp End 1,786,019,400
Earnings Timestamp Start 1,786,019,400
Ebitda -122,681,000
Ebitda Margins 0.0
Enterprise To Ebitda -0.545
Enterprise Value 66,854,456
Eps Current Year -1.1125
Eps Forward -1.1125
Eps Trailing Twelve Months -2.49
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 4.2596
Fifty Day Average Change -0.41960025
Fifty Day Average Change Percent -0.09850696
Fifty Two Week Change Percent 97.93814
Fifty Two Week High 5.495
Fifty Two Week High Change -1.655
Fifty Two Week High Change Percent -0.3011829
Fifty Two Week Low 1.57
Fifty Two Week Low Change 2.27
Fifty Two Week Low Change Percent 1.4458598
Fifty Two Week Range 1.57 - 5.495
Financial Currency USD
First Trade Date Milliseconds 1,518,791,400,000
Float Shares 20,586,566
Forward Eps -1.1125
Forward P E -3.4516854
Free Cashflow -68,453,000
Full Exchange Name NasdaqCM
Full Time Employees 29
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.0
Gross Profits -99,407,000
Has Pre Post Market Data 1
Held Percent Insiders 0.13381
Held Percent Institutions 0.72730005
Implied Shares Outstanding 49,452,463
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,630,022,400
Last Split Factor 1:15
Long Business Summary Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Long Name Whitehawk Therapeutics, Inc.
Market us_market
Market Cap 189,897,456
Market State PRE
Max Age 86,400
Message Board Id finmb_430225247
Most Recent Quarter 1,774,915,200
Name Change Date 2,026-07-14
Net Income To Common -115,806,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 189,897,457
Number Of Analyst Opinions 6
Open 4.0
Operating Cashflow -107,777,000
Operating Margins 0.0
Overall Risk 8
Payout Ratio 0.0
Phone 551 321 2234
Prev Name Aadi Bioscience, Inc.
Previous Close 3.97
Price Eps Current Year -3.4516854
Price Hint 4
Price To Book 1.5597076
Price To Sales Trailing12 Months Infinity
Profit Margins 0.0
Quick Ratio 11.129
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.875
Region US
Regular Market Change -0.13
Regular Market Change Percent -3.27456
Regular Market Day High 4.06
Regular Market Day Low 3.81
Regular Market Day Range 3.81 - 4.06
Regular Market Open 4.0
Regular Market Previous Close 3.97
Regular Market Price 3.84
Regular Market Time 1,783,972,800
Regular Market Volume 503,750
Return On Assets -0.4246
Return On Equity -0.68544
Revenue Per Share 0.0
Sand P52 Week Change 0.20365608
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 49,452,463
Shares Percent Shares Out 0.0573
Shares Short 2,833,866
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 843,660
Short Name Whitehawk Therapeutics, Inc.
Short Percent Of Float 0.102
Short Ratio 5.55
Source Interval 15
State NJ
Symbol WHWK
Target High Price 10.0
Target Low Price 4.0
Target Mean Price 7.5
Target Median Price 7.5
Total Cash 123,043,000
Total Cash Per Share 2.488
Total Debt 0
Total Revenue 0
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -2.49
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.18805
Two Hundred Day Average Change 0.6519499
Two Hundred Day Average Change Percent 0.20449801
Type Disp Equity
Volume 503,750
Website https://ir.whitehawktx.com
Zip 7,960